drugset / Trial / NCT00193271
Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This trial will evaluate the feasibility, toxicity, and efficacy of docetaxel/estramustine, as in the adjuvant therapy of patients with high-risk prostate cancer after definitive local therapy.
Timeline
- Start
- 2004-08
- Primary completion
- 2007-05
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | — |
| Subject | estramustine | Other / unclassified | — | — |